For: | Liu XL, Cao HX, Wang BC, Xin FZ, Zhang RN, Zhou D, Yang RX, Zhao ZH, Pan Q, Fan JG. miR-192-5p regulates lipid synthesis in non-alcoholic fatty liver disease through SCD-1. World J Gastroenterol 2017; 23(46): 8140-8151 [PMID: PMC5739921 DOI: 10.3748/wjg.v23.i46.8140] |
---|---|
URL: | https://www.wjgnet.com/1948-5182/full/v23/i46/8140.htm |
Number | Citing Articles |
1 |
Juanjuan Cui, Yang Wang, Haowei Xue. Long non-coding RNA GAS5 contributes to the progression of nonalcoholic fatty liver disease by targeting the microRNA-29a-3p/NOTCH2 axis. Bioengineered 2022; 13(4): 8370 doi: 10.1080/21655979.2022.2026858
|
2 |
Shreya C. Pal, Mohammed Eslam, Nahum Mendez-Sanchez. Detangling the interrelations between MAFLD, insulin resistance, and key hormones. Hormones 2022; 21(4): 573 doi: 10.1007/s42000-022-00391-w
|
3 |
Farzaneh Kefayati, Atoosa Karimi Babaahmadi, Taraneh Mousavi, Mahshid Hodjat, Mohammad Abdollahi. Epigenotoxicity: a danger to the future life. Journal of Environmental Science and Health, Part A 2023; 58(4): 382 doi: 10.1080/10934529.2023.2190713
|
4 |
Andrea R. López-Pastor, Jorge Infante-Menéndez, Óscar Escribano, Almudena Gómez-Hernández. miRNA Dysregulation in the Development of Non-Alcoholic Fatty Liver Disease and the Related Disorders Type 2 Diabetes Mellitus and Cardiovascular Disease. Frontiers in Medicine 2020; 7 doi: 10.3389/fmed.2020.527059
|
5 |
Costanza Renata Neri, Serena Scapaticci, Francesco Chiarelli, Cosimo Giannini. Liver Steatosis: A Marker of Metabolic Risk in Children. International Journal of Molecular Sciences 2022; 23(9): 4822 doi: 10.3390/ijms23094822
|
6 |
Youngseok Lee, Jong-Hoon Kim. The emerging roles of extracellular vesicles as intercellular messengers in liver physiology and pathology. Clinical and Molecular Hepatology 2022; 28(4): 706 doi: 10.3350/cmh.2021.0390
|
7 |
Daniel Geh, Quentin M Anstee, Helen L Reeves. NAFLD-Associated HCC: Progress and Opportunities. Journal of Hepatocellular Carcinoma 2021; : 223 doi: 10.2147/JHC.S272213
|
8 |
J. Samael Rodríguez-Sanabria, Rebeca Escutia-Gutiérrez, Rebeca Rosas-Campos, Juan S. Armendáriz-Borunda, Ana Sandoval-Rodríguez. An Update in Epigenetics in Metabolic-Associated Fatty Liver Disease. Frontiers in Medicine 2022; 8 doi: 10.3389/fmed.2021.770504
|
9 |
Shengyang Ji, Feiran Xu, Na Zhang, Ying Wu, Xingrong Ju, Lifeng Wang. Dietary a novel structured lipid synthesized by soybean oil and coconut oil alter fatty acid metabolism in C57BL/6J mice. Food Bioscience 2021; 44: 101396 doi: 10.1016/j.fbio.2021.101396
|
10 |
Li-Min Wei, Rui-Ping Sun, Tao Dong, Jie Liu, Ting Chen, Bin Zeng, Jia-Han Wu, Jun-yi Luo, Jia-Jie Sun, Qian-Yun Xi, Yong-Liang Zhang. MiR-125b-2 knockout increases high-fat diet-induced fat accumulation and insulin resistance. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-77714-7
|
11 |
Bo Zhu, Hao Wu, Kathryn S. Li, Shahram Eisa-Beygi, Bandana Singh, Diane R. Bielenberg, Wendong Huang, Hong Chen. Two sides of the same coin: Non-alcoholic fatty liver disease and atherosclerosis. Vascular Pharmacology 2024; 154: 107249 doi: 10.1016/j.vph.2023.107249
|
12 |
Ali Mahmoudi, Alexandra E. Butler, Tannaz Jamialahmadi, Amirhossein Sahebkar. The role of exosomal miRNA in nonalcoholic fatty liver disease. Journal of Cellular Physiology 2022; 237(4): 2078 doi: 10.1002/jcp.30699
|
13 |
Ruitang Shi, Haoqing Yang, Xiao Lin, Yangyang Cao, Chen Zhang, Zhipeng Fan, Benxiang Hou. Analysis of the characteristics and expression profiles of coding and noncoding RNAs of human dental pulp stem cells in hypoxic conditions. Stem Cell Research & Therapy 2019; 10(1) doi: 10.1186/s13287-019-1192-2
|
14 |
Alan Eduardo Botello-Manilla, Norberto Carlos Chávez-Tapia, Misael Uribe, Natalia Nuño-Lámbarri. Genetics and epigenetics purpose in nonalcoholic fatty liver disease. Expert Review of Gastroenterology & Hepatology 2020; 14(8): 733 doi: 10.1080/17474124.2020.1780915
|
15 |
Ashok Mandala, Rachel C. Janssen, Sirish Palle, Kevin R. Short, Jacob E. Friedman. Pediatric Non-Alcoholic Fatty Liver Disease: Nutritional Origins and Potential Molecular Mechanisms. Nutrients 2020; 12(10): 3166 doi: 10.3390/nu12103166
|
16 |
Yandong Liu, Chao Wang, Wei Huan, Sili Zou, Yong Zuo, Lefeng Qu. MiR-127-3p Regulates Macrophagic Fatty Acid and Cholesterol Metabolism in Promoting Atherosclerotic Lesion Development. SSRN Electronic Journal 2022; doi: 10.2139/ssrn.4115768
|
17 |
Namju Kim, Hokyung Choung, Yu Jeong Kim, Sang Earn Woo, Min Kyu Yang, Sang In Khwarg, Min Joung Lee. Serum microRNA as a potential biomarker for the activity of thyroid eye disease. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-27483-w
|
18 |
Zhou Liu, Xiaojian Yin, Hui Mai, Guangning Li, Zhijun Lin, Wanxin Jie, Kanglan Li, Haihong Zhou, Shouchao Wei, Li Hu, Wanjuan Peng, Jiajing Lin, Feng Yao, Hua Tao, Xing‐dong Xiong, Keshen Li. SCD rs41290540 single‐nucleotide polymorphism modifies miR‐498 binding and is associated with a decreased risk of coronary artery disease. Molecular Genetics & Genomic Medicine 2020; 8(3) doi: 10.1002/mgg3.1136
|
19 |
Jiatong Xu, Yifan Li, Zixuan Feng, Hongping Chen. Cigarette Smoke Contributes to the Progression of MASLD: From the Molecular Mechanisms to Therapy. Cells 2025; 14(3): 221 doi: 10.3390/cells14030221
|
20 |
Bin Zhang, Xuelian Zhang, Chenyang Zhang, Guibo Sun, Xiaobo Sun. Berberine Improves the Protective Effects of Metformin on Diabetic Nephropathy in db/db Mice through Trib1-dependent Inhibiting Inflammation. Pharmaceutical Research 2021; 38(11): 1807 doi: 10.1007/s11095-021-03104-x
|
21 |
Jie Liu, Yue Xiao, Xikun Wu, Lichun Jiang, Shurong Yang, Zhiming Ding, Zhuo Fang, Haiqing Hua, Mark Stephen Kirby, Jianyong Shou. A circulating microRNA signature as noninvasive diagnostic and prognostic biomarkers for nonalcoholic steatohepatitis. BMC Genomics 2018; 19(1) doi: 10.1186/s12864-018-4575-3
|
22 |
Faraz Mahdizadeh, Pouria Sobhi, Shokofeh Banaei. A Class of MicroRNAs as Diagnostic Biomarkers and Therapeutic Strategies in Non-Alcoholic Fatty Liver Disease. Clinics and Research in Hepatology and Gastroenterology 2025; : 102547 doi: 10.1016/j.clinre.2025.102547
|
23 |
Julie Sanceau, Angélique Gougelet. Clinical Applications of Non-Coding RNAs in Cancer. 2022; : 343 doi: 10.1016/B978-0-12-824550-7.00007-2
|
24 |
Shabnam Radbakhsh, Thozhukat Sathyapalan, Maciej Banach, Amirhossein Sahebkar. Incretins and microRNAs: Interactions and physiological relevance. Pharmacological Research 2020; 153: 104662 doi: 10.1016/j.phrs.2020.104662
|
25 |
Jukka Hintikka, Sanna Lensu, Elina Mäkinen, Sira Karvinen, Marjaana Honkanen, Jere Lindén, Tim Garrels, Satu Pekkala, Leo Lahti. Xylo-Oligosaccharides in Prevention of Hepatic Steatosis and Adipose Tissue Inflammation: Associating Taxonomic and Metabolomic Patterns in Fecal Microbiomes with Biclustering. International Journal of Environmental Research and Public Health 2021; 18(8): 4049 doi: 10.3390/ijerph18084049
|
26 |
Miguel Angel Martinez, Cristina Tural, Sandra Franco. Circulating MicroRNAs as a Tool for Diagnosis of Liver Disease Progression in People Living with HIV-1. Viruses 2022; 14(6): 1118 doi: 10.3390/v14061118
|
27 |
Setu Chakraborty, Nardos T. Woldemariam, Tina Visnovska, Matthew L. Rise, Danny Boyce, Javier Santander, Rune Andreassen. Characterization of miRNAs in Embryonic, Larval, and Adult Lumpfish Provides a Reference miRNAome for Cyclopterus lumpus. Biology 2022; 11(1): 130 doi: 10.3390/biology11010130
|
28 |
Chunyu Bai, Hongwei Zhang, Xiangyang Zhang, Wancai Yang, Xiangchen Li, Yuhua Gao. MiR-15/16 mediate crosstalk between the MAPK and Wnt/β-catenin pathways during hepatocyte differentiation from amniotic epithelial cells. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms 2019; 1862(5): 567 doi: 10.1016/j.bbagrm.2019.02.003
|
29 |
Baige Cao, Chongxiao Liu, Qianren Zhang, Yan Dong. Maternal High-Fat Diet Leads to Non-alcoholic Fatty Liver Disease Through Upregulating Hepatic SCD1 Expression in Neonate Rats. Frontiers in Nutrition 2020; 7 doi: 10.3389/fnut.2020.581723
|
30 |
María I. Fontalba-Romero, Soledad Lopez-Enriquez, Ana Lago-Sampedro, Eva García-Escobar, Ricardo L. Pastori, Juan Domínguez-Bendala, Silvia Álvarez-Cubela, Sergio Valdes, Gemma Rojo, Eduardo Garcia-Fuentes, María T. Labajos-Manzanares, Sara García-Serrano. Association between the Mediterranean Diet and Metabolic Syndrome with Serum Levels of miRNA in Morbid Obesity. Nutrients 2021; 13(2): 436 doi: 10.3390/nu13020436
|
31 |
Xiao‐Lin Liu, Qin Pan, Hai‐Xia Cao, Feng‐Zhi Xin, Ze‐Hua Zhao, Rui‐Xu Yang, Jing Zeng, Huiping Zhou, Jian‐Gao Fan. Lipotoxic Hepatocyte‐Derived Exosomal MicroRNA 192‐5p Activates Macrophages Through Rictor/Akt/Forkhead Box Transcription Factor O1 Signaling in Nonalcoholic Fatty Liver Disease. Hepatology 2020; 72(2): 454 doi: 10.1002/hep.31050
|
32 |
Yihong Chu, Aimei Yu, Huanbin Wang, Shahid Ali Rajput, Qianqian Yu, Desheng Qi. Biological Mechanisms of Aflatoxin B1-Induced Bile Metabolism Abnormalities in Ducklings. Animals 2024; 14(20): 2996 doi: 10.3390/ani14202996
|
33 |
Cheng Chen, Xin Xin, Qian Liu, Hua-Jie Tian, Jing-Hua Peng, Yu Zhao, Yi-Yang Hu, Qin Feng. Geniposide and Chlorogenic Acid Combination Improves Non-Alcoholic Fatty Liver Disease Involving the Potent Suppression of Elevated Hepatic SCD-1. Frontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.653641
|
34 |
Xiangyang Wang, Hua Cai, Zhiyuan Chen, Yu Zhang, Minghao Wu, Xiaoping Xu, Li Yang. Baicalein alleviates pyroptosis and inflammation in hyperlipidemic pancreatitis by inhibiting NLRP3/Caspase-1 pathway through the miR-192-5p/TXNIP axis. International Immunopharmacology 2021; 101: 108315 doi: 10.1016/j.intimp.2021.108315
|
35 |
Mi Jeong Heo, Jessica Yun, Sang Geon Kim. Role of non-coding RNAs in liver disease progression to hepatocellular carcinoma. Archives of Pharmacal Research 2019; 42(1): 48 doi: 10.1007/s12272-018-01104-x
|
36 |
Anirban Goutam Mukherjee, Uddesh Ramesh Wanjari, Abilash Valsala Gopalakrishnan, Ramkumar Katturajan, Sandra Kannampuzha, Reshma Murali, Arunraj Namachivayam, Raja Ganesan, Kaviyarasi Renu, Abhijit Dey, Balachandar Vellingiri, Sabina Evan Prince. Exploring the Regulatory Role of ncRNA in NAFLD: A Particular Focus on PPARs. Cells 2022; 11(24): 3959 doi: 10.3390/cells11243959
|
37 |
Yu Sun, Yongming Shen, Xiurui Liang, Huilin Zheng, Yitong Zhang. MicroRNAs as Biomarkers and Therapeutic Targets for Nonalcoholic Fatty Liver Disease: A Narrative Review. Clinical Therapeutics 2023; 45(3): 234 doi: 10.1016/j.clinthera.2023.02.001
|
38 |
Ali Mahmoudi, Mehdi Rostami, Mohammad Mahdi Hajihasani, Vasily N. Sukhorukov, Prashant Kesharwani, Amirhossein Sahebkar. siRNA-mediated gene silencing for non-alcoholic fatty liver disease: A comprehensive review of molecular targets. European Polymer Journal 2024; 208: 112866 doi: 10.1016/j.eurpolymj.2024.112866
|
39 |
Yunfeng Shen, Lidan Cheng, Minxuan Xu, Wei Wang, Zhiping Wan, Haixia Xiong, Wanrong Guo, Mengyin Cai, Fen Xu. SGLT2 inhibitor empagliflozin downregulates miRNA-34a-5p and targets GREM2 to inactivate hepatic stellate cells and ameliorate non-alcoholic fatty liver disease-associated fibrosis. Metabolism 2023; 146: 155657 doi: 10.1016/j.metabol.2023.155657
|
40 |
Yang Hu, Yongming Yu. Dysregulation of miR-192-5p in acute pancreatitis patients with nonalcoholic fatty liver and its functional role in acute pancreatitis progression. Bioscience Reports 2020; 40(5) doi: 10.1042/BSR20194345
|
41 |
Charalampos K. Giannopoulos, Ioanna G. Tzima, Nikolaos K. Tentolouris, Ioannis A. Vasileiadis. Common Pathogenetic Pathways of Non-Alcoholic Fatty Liver Disease and
Type 2 Diabetes Mellitus. Current Diabetes Reviews 2023; 19(9) doi: 10.2174/1573399819666230216112032
|
42 |
Juliette Schönberg, Jürgen Borlak. miRNA biomarkers to predict risk of primary non-function of fatty allografts and drug induced acute liver failures. Molecular and Cellular Biochemistry 2024; doi: 10.1007/s11010-024-05129-3
|
43 |
Tanapa Suksangrat, Phatchariya Phannasil, Sarawut Jitrapakdee. Reviews on Biomarker Studies of Metabolic and Metabolism-Related Disorders. Advances in Experimental Medicine and Biology 2019; 1134: 129 doi: 10.1007/978-3-030-12668-1_7
|
44 |
Minkai Cao, Deping Yuan, Hongxiu Jiang, Guanlun Zhou, Chao Chen, Guorong Han. Long non-coding RNA WAC antisense RNA 1 mediates hepatitis B virus replication <em>in vitro</em> by reinforcing miR-192-5p/ATG7-induced autophagy. European Journal of Histochemistry 2022; 66(3) doi: 10.4081/ejh.2022.3438
|
45 |
Masoumeh Farahani, Mostafa Rezaei‐Tavirani, Babak Arjmand. A systematic review of microRNA expression studies with exposure to bisphenol A. Journal of Applied Toxicology 2021; 41(1): 4 doi: 10.1002/jat.4025
|
46 |
Miguel A. Bermúdez, Laura Pereira, Cristina Fraile, Laura Valerio, María A. Balboa, Jesús Balsinde. Roles of Palmitoleic Acid and Its Positional Isomers, Hypogeic and Sapienic Acids, in Inflammation, Metabolic Diseases and Cancer. Cells 2022; 11(14): 2146 doi: 10.3390/cells11142146
|
47 |
Zhangting Wang, Kai-Kei Miu, Xueyan Zhang, Angel Tsz-Yau Wan, Gang Lu, Hoi-Hung Cheung, Heung-Man Lee, Alice Pik-Shan Kong, Juliana Chung-Ngor Chan, Wai-Yee Chan. Hepatic miR-192-3p reactivation alleviates steatosis by targeting glucocorticoid receptor. JHEP Reports 2020; 2(6): 100179 doi: 10.1016/j.jhepr.2020.100179
|
48 |
Fu-jia Ren, Yao Yao, Xiao-yu Cai, Guo-ying Fang. Emerging Role of MiR-192-5p in Human Diseases. Frontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.614068
|
49 |
Chunye Zhang, Ming Yang. Current Options and Future Directions for NAFLD and NASH Treatment. International Journal of Molecular Sciences 2021; 22(14): 7571 doi: 10.3390/ijms22147571
|
50 |
Zhila Bahramirad, Mohammad Raman Moloudi, Mohammad Moradzad, Alina Abdollahi, Zakaria Vahabzadeh. Trimethylamine-N-oxide, a New Risk Factor for Non-alcoholic Fatty Liver Disease Changes the Expression of miRNA-34a, and miRNA-122 in the Fatty Liver Cell Model. Biochemical Genetics 2024; doi: 10.1007/s10528-024-10754-0
|
51 |
Zhi Chen, Qinyue Lu, Xinlong Zhang, Zhiyue Zhang, Xiang Cao, Kun Wang, Xiaotan Lu, Zhangping Yang, Juan J. Loor, Peixin Jiao. Circ007071 Inhibits Unsaturated Fatty Acid Synthesis by Interacting with miR-103-5p to Enhance PPARγ Expression in the Dairy Goat Mammary Gland. Journal of Agricultural and Food Chemistry 2022; 70(42): 13719 doi: 10.1021/acs.jafc.2c06174
|
52 |
Yunxia Dong, Henglei Lu, Qiang Li, Xinming Qi, Yuanchao Li, Zean Zhang, Jing Chen, Jin Ren. (5R)-5-hydroxytriptolide ameliorates liver lipid accumulation by suppressing lipid synthesis and promoting lipid oxidation in mice. Life Sciences 2019; 232: 116644 doi: 10.1016/j.lfs.2019.116644
|
53 |
Zhixin Ye, Songzi Wang, Xiaoqing Huang, Peisong Chen, Langhui Deng, Shiqi Li, Suiwen Lin, Zilian Wang, Bin Liu. Plasma Exosomal miRNAs Associated With Metabolism as Early Predictor of Gestational Diabetes Mellitus. Diabetes 2022; 71(11): 2272 doi: 10.2337/db21-0909
|
54 |
Halla M. Ragab, Wafaa M. Ezzat, Eman Mahmoud Hassan, Nabila Abd El Maksoud, Mie Afify, Mohamed D.E. Abd El-Maksoud, Wafaa Abd Elaziz. Significance of MiRNA-34a and MiRNA-192 as a risk factor for nonalcoholic fatty liver disease. Journal of Genetic Engineering and Biotechnology 2023; 21(1): 13 doi: 10.1186/s43141-023-00467-z
|
55 |
Xuedong Wang, Yuansi Zheng, Yan Ma, Liyang Du, Fangyu Chu, Haidong Gu, Randy A. Dahlgren, Yanyan Li, Huili Wang. Lipid metabolism disorder induced by up-regulation of miR-125b and miR-144 following β-diketone antibiotic exposure to F0-zebrafish (Danio rerio). Ecotoxicology and Environmental Safety 2018; 164: 243 doi: 10.1016/j.ecoenv.2018.08.027
|
56 |
Gaetan Ravaut, Alexandre Légiot, Karl-F. Bergeron, Catherine Mounier. Monounsaturated Fatty Acids in Obesity-Related Inflammation. International Journal of Molecular Sciences 2020; 22(1): 330 doi: 10.3390/ijms22010330
|
57 |
Shashi Bala, Mrigya Babuta, Donna Catalano, Aman Saiju, Gyongyi Szabo. Alcohol Promotes Exosome Biogenesis and Release via Modulating Rabs and miR-192 Expression in Human Hepatocytes. Frontiers in Cell and Developmental Biology 2022; 9 doi: 10.3389/fcell.2021.787356
|
58 |
Ioana Rusu, Radu Pirlog, Paul Chiroi, Andreea Nutu, Vlad Radu Puia, Alin Cornel Fetti, Daniel Radu Rusu, Ioana Berindan-Neagoe, Nadim Al Hajjar. The Implications of Noncoding RNAs in the Evolution and Progression of Nonalcoholic Fatty Liver Disease (NAFLD)-Related HCC. International Journal of Molecular Sciences 2022; 23(20): 12370 doi: 10.3390/ijms232012370
|
59 |
Kequan Xu, Peng Xia, Xi Chen, Weijie Ma, Yufeng Yuan. ncRNA-mediated fatty acid metabolism reprogramming in HCC. Trends in Endocrinology & Metabolism 2023; 34(5): 278 doi: 10.1016/j.tem.2023.02.007
|
60 |
Bo Zhu, Siu-Lung Chan, Jack Li, Kathryn Li, Hao Wu, Kui Cui, Hong Chen. Non-alcoholic Steatohepatitis Pathogenesis, Diagnosis, and Treatment. Frontiers in Cardiovascular Medicine 2021; 8 doi: 10.3389/fcvm.2021.742382
|
61 |
María DeLucas, Juana Sánchez, Andreu Palou, Francisca Serra. The Impact of Diet on miRNA Regulation and Its Implications for Health: A Systematic Review. Nutrients 2024; 16(6): 770 doi: 10.3390/nu16060770
|
62 |
Xiaoxia Liu, Ke Zhao, Nana Jing, Yan Zhao, Xingbin Yang. EGCG regulates fatty acid metabolism of high-fat diet-fed mice in association with enrichment of gut Akkermansia muciniphila. Journal of Functional Foods 2020; 75: 104261 doi: 10.1016/j.jff.2020.104261
|
63 |
Polina Soluyanova, Guillermo Quintás, Álvaro Pérez-Rubio, Iván Rienda, Erika Moro, Marcel van Herwijnen, Marcha Verheijen, Florian Caiment, Judith Pérez-Rojas, Ramón Trullenque-Juan, Eugenia Pareja, Ramiro Jover. The Development of a Non-Invasive Screening Method Based on Serum microRNAs to Quantify the Percentage of Liver Steatosis. Biomolecules 2024; 14(11): 1423 doi: 10.3390/biom14111423
|
64 |
Yuanjie Yu, Jie Zhu, Juan Liu, Mengjun Huang, Jin‐Xiang Wan. Identification of 8‐miRNAs as biomarkers for nonalcoholic fatty liver disease. Journal of Cellular Physiology 2019; 234(10): 17361 doi: 10.1002/jcp.28356
|
65 |
Can Li, Yuhan Zhang, Yueting Ge, Bin Qiu, Di Zhang, Xianshu Wang, Wei Liu, Haiteng Tao. Comparative transcriptome and microbiota analyses provide new insights into the adverse effects of industrial trans fatty acids on the small intestine of C57BL/6 mice. European Journal of Nutrition 2021; 60(2): 975 doi: 10.1007/s00394-020-02297-y
|
66 |
Reda M. Mansour, Sherif S. Abdel Mageed, Ahmed I. Abulsoud, Ghadir A Sayed, Radwa H. Lutfy, Farah A. Awad, Mohamed M. Sadek, Abanoub A. S. Shaker, Osama A. Mohammed, Mustafa Ahmed Abdel-Reheim, Hanan Elimam, Ahmed S. Doghish. From fatty liver to fibrosis: the impact of miRNAs on NAFLD and NASH. Functional & Integrative Genomics 2025; 25(1) doi: 10.1007/s10142-025-01544-x
|